Vanguard Group Inc. Reduces Holdings in Agilon Health, Inc. $AGL

Key Points

• Vanguard Group Inc. reduced its stake in Agilon Health by 2.7%, selling 826,647 shares and now holding approximately 30.3 million shares valued at $131.1 million.
• Several analysts have downgraded their target prices for Agilon Health, with Benchmark lowering it from $4.00 to $1.50 and Jefferies reducing theirs from $2.40 to $1.10.
• Agilon Health reported a loss of ($0.25) per share in its latest earnings, missing the consensus estimate and experiencing a 5.9% revenue decline compared to the previous year.

Vanguard Group Inc. lessened its holdings in Agilon Health, Inc. (NYSE:AGL - Free Report) by 2.7% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 30,285,760 shares of the company's stock after selling 826,647 shares during the quarter. Vanguard Group Inc. owned approximately 7.33% of Agilon Health worth $131,137,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently modified their holdings of the company. Humankind Investments LLC acquired a new stake in Agilon Health during the fourth quarter worth about $30,000. Raymond James Financial Inc. purchased a new stake in Agilon Health in the fourth quarter valued at $33,000. Cerity Partners LLC purchased a new stake in Agilon Health in the fourth quarter valued at $34,000. Nisa Investment Advisors LLC grew its stake in shares of Agilon Health by 244.9% in the first quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock valued at $41,000 after buying an additional 6,783 shares in the last quarter. Finally, Boothbay Fund Management LLC acquired a new position in Agilon Health during the 4th quarter worth $58,000.

Wall Street Analysts Forecast Growth

Several analysts have commented on the company. Barclays reduced their price objective on Agilon Health from $3.00 to $1.50 and set an "underweight" rating for the company in a research note on Wednesday, August 6th. Jefferies Financial Group lowered their target price on Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a research note on Friday, August 15th. The Goldman Sachs Group raised their target price on shares of Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. JMP Securities reissued a "market perform" rating on shares of Agilon Health in a report on Monday, April 28th. Finally, Robert W. Baird dropped their price target on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average target price of $3.07.

Agilon Health Stock Performance

AGL stock traded down $0.16 during mid-day trading on Tuesday, hitting $1.23. 4,995,414 shares of the company were exchanged, compared to its average volume of 7,222,973. The firm's 50 day simple moving average is $1.84 and its 200 day simple moving average is $2.97. The firm has a market cap of $507.67 million, a P/E ratio of -1.59 and a beta of 0.14. Agilon Health, Inc. has a 1-year low of $0.71 and a 1-year high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by ($0.14). The business had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. Agilon Health's revenue was down 5.9% on a year-over-year basis. During the same period in the previous year, the business posted ($0.07) EPS. On average, equities research analysts predict that Agilon Health, Inc. will post -0.59 EPS for the current fiscal year.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.